ANDREWS DEBORAH J — SEC insider filings

SEC reporting owner CIK 1325697. 14 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2021-06-30 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lineage Cell Therapeutics, Inc. (LCTX)Director81 leg · 25,000 sh · $20,0001 leg · 19,142 sh · $56,0868
STAAR SURGICAL CO (STAA)Chief Financial Officer & EVP6——21

Insider filings — ANDREWS DEBORAH J

FiledFormIssuerReported transactionsSource
2026-11-174Lineage Cell Therapeutics, Inc. (LCTX)Purchase (P): 25,000 @ $0.80EDGAR
2026-08-184STAAR SURGICAL CO (STAA)Option exercise (M): 5,233 @ $0 · Tax withholding (F): 2,662 @ $26.18 · Grant/award (A): 4,975 (derivative) @ $0 · Grant/award (A): 8,952 (derivative) @ $0 · Grant/award (A): 29,159 (derivative) @ $0 · Option exercise (M): 5,233 (derivative) @ $0EDGAR
2026-08-044STAAR SURGICAL CO (STAA)Option exercise (M): 13,955 · Tax withholding (F): 6,480 @ $31.21 · Option exercise (M): 20,787 · Tax withholding (F): 10,576 @ $24.36 · Option exercise (M): 13,955 (derivative) @ $0 · Option exercise (M): 20,787 (derivative) @ $0EDGAR
2026-07-024Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2026-05-194STAAR SURGICAL CO (STAA)Grant/award (A): 10,466 @ $0 · Tax withholding (F): 3,755 @ $32.07 · Grant/award (A): 5,233 @ $0 · Tax withholding (F): 1,877 @ $32.07 · Option exercise (M): 10,466 (derivative) @ $0 · Option exercise (M): 5,233 (derivative) @ $0EDGAR
2026-03-164STAAR SURGICAL CO (STAA)Grant/award (A): 39,809 (derivative) @ $0EDGAR
2026-02-044STAAR SURGICAL CO (STAA)Grant/award (A): 20,787 (derivative) @ $0EDGAR
2025-07-024Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2025-06-264STAAR SURGICAL CO (STAA)Grant/award (A): 41,867 (derivative) @ $0EDGAR
2024-07-034Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2023-07-034Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-07-064Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2021-07-014Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2021-06-304Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 24,720 @ $2.20 · Sale (S): 19,142 @ $2.93 · Option exercise (M): 24,720 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1325697 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs